Vericel (VCEL) Finished Goods (2014 - 2026)
Vericel's (VCEL) quarterly Finished Goods came in at $3.1 million in Q1 2026, down 16.11% year-on-year from $3.7 million in Q1 2025, and up 2.32% quarter-over-quarter from $3.0 million in Q4 2025.
Vericel (VCEL) Finished Goods (2014 - 2026) Analysis & Trends
Vericel has disclosed Finished Goods across 13 years of filings, most recently posting $3.1 million for Q1 2026.
- Finished Goods for Q1 2026 came in at $3.1 million, down 16.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (down 16.11% YoY), and the FY2025 annual result was $3.0 million, up 1.61% from the prior year.
- Finished Goods came in at $3.1 million for Q1 2026 at Vericel, up from $3.0 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $4.0 million in Q3 2025 to a low of $49000.0 in Q3 2022.
- The 5-year median for Finished Goods is $954000.0 (2024), against an average of $1.5 million.
- Across the five-year window, Finished Goods decreased 27.94% in 2022 and jumped 1414.29% in 2024, its largest moves.
- Vericel's Finished Goods stood at $53000.0 in 2022, then surged by 898.11% to $529000.0 in 2023, then jumped by 462.38% to $3.0 million in 2024, then gained by 1.61% to $3.0 million in 2025, then advanced by 2.32% to $3.1 million in 2026.
- The last three Finished Goods figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.09 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 954,000.00 |
| Dec 31, 2023 | 529,000.00 |
| Sep 30, 2023 | 218,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 63,000.00 |
| Dec 31, 2022 | 53,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 71,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 68,000.00 |